BiotechTube

Rocuronium bromide + Rocuronium bromide + Rocuronium bromide + Sevoflurane + Propofol

Phase 3Completed
0 watching 0 views this week๐Ÿ“ˆ Rising
77
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Anesthesia

Conditions

Anesthesia

Trial Timeline

May 1, 2003 โ†’ Sep 1, 2003

NCT ID
NCT00988520

About Rocuronium bromide + Rocuronium bromide + Rocuronium bromide + Sevoflurane + Propofol

Rocuronium bromide + Rocuronium bromide + Rocuronium bromide + Sevoflurane + Propofol is a phase 3 stage product being developed by Merck for Anesthesia. The current trial status is completed. This product is registered under clinical trial identifier NCT00988520. Target conditions include Anesthesia.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00988520Phase 3Completed

Competing Products

20 competing products in Anesthesia

See all competitors
ProductCompanyStageHype Score
Fospropofol disodium, propofol + Fospropofol disodium, propofol + Fospropofol disodium, propofolEisaiApproved
85
arm 1 + LUSEDRA + Propofol (arm 3)EisaiPhase 1
33
Remimazolam Tosilate for InjectionJiangsu Hengrui MedicinePre-clinical
23
Remimazolam Tosilate + PropofolJiangsu Hengrui MedicinePhase 3
77
Remimazolam TosylateJiangsu Hengrui MedicinePhase 1
33
HR020602 injection + fentanyl injection ๏ผ› remifentanil injectionJiangsu Hengrui MedicinePhase 2
52
Remimazolam Tosilate + PropofolJiangsu Hengrui MedicinePhase 2
52
Remimazolam Tosilate + Propofol Injection.Jiangsu Hengrui MedicinePhase 2
52
Ropivacaine + BupivacaineAstraZenecaPhase 3
77
SugammadexMerckPhase 2
52
SugammadexMerckPhase 2
52
Sugammadex + neostigmineMerckPhase 3
77
Sugammadex + Rocuronium + Sevoflurane + PropofolMerckPhase 3
77
Rocuronium + Sugammadex + Neostigmine + AtropineMerckPhase 3
77
Rocuronium 0.6 mg/kg intubating dose + Rocuronium 0.9 mg/kg intubating dose + Rocuronium 0.1 mg/kg maintenance dose + Rocuronium 0.15 mg/kg maintenance dose + Rocuronium 0.2 mg/kg maintenance + Vecuronium 0.1 mg/kg intubating dose + Vecuronium 0.025 mg/kg maintenance doseMerckPhase 3
77
Rocuronium bolus maintenance + rocuronium continuous infusion maintenanceMerckPhase 3
77
Sugammadex + RocuroniumMerckPhase 3
77
Sugammadex + NeostigmineMerckPhase 3
77
sugammadexMerckPhase 3
77
Sugammadex + Succinylcholine + RocuroniumMerckPhase 3
77

Other Products from Merck

DuleraApproved
85
ImipenemApproved
85
MavencladยฎApproved
85
raltegravir + PlaceboApproved
85
alendronate sodiumApproved
85